Medtronic plc (MDT)
| Previous Close | 80.89 |
| Open | 81.44 |
| Bid | 80.49 x 800 |
| Ask | 80.49 x 1300 |
| Day's Range | 80.14 - 81.71 |
| 52 Week Range | 68.84 - 91.00 |
| Volume | |
| Avg. Volume | 6,299,409 |
| Market Cap | 106.916B |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | 25.56 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.76 (3.41%) |
| Ex-Dividend Date | Mar 21, 2024 |
| 1y Target Est | N/A |
- ACCESSWIRE
Medtronic: 'Pivotal Moment' in Women's Heart Health
Female-specific results from first-of-its-kind clinical trial NORTHAMPTON, MA / ACCESSWIRE / May 1, 2024 / Teaching first graders takes a lot of energy. So when Julia Garcia started feeling worn out, teaching became extremely difficult. "I got very ...
- PR Newswire
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
- ACCESSWIRE
Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity
According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN, IRELAND / ACCESSWIRE / April 19, 2024 / Americans overwhelmingly ...
